Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.

被引:0
|
作者
Kariburyo-Yay, Furaha
George, Daniel J.
Aggarwal, Himani
Tepsick, Jon G.
Yu, Rebekah
Li, Weiyan
Orji, Chinelo
Lal, Lincy S.
Ghate, Sameer R.
机构
[1] ConcertAI LLC, Cambridge, MA USA
[2] Duke Univ, Inst Canc, Durham, NC USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] AstraZeneca, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5054
引用
收藏
页数:1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF OLAPARIB COMPARED TO RUCAPARIB FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN UNITED STATES
    Ghule, P.
    Kohli, M.
    Malone, D. C.
    Nelson, R. E.
    VALUE IN HEALTH, 2022, 25 (07) : S428 - S429
  • [22] Real-world (RW) overall survival (OS) with enzalutamide (ENZ) and abiraterone acetate (ABI) in patients (pts) with chemotherapy (cx)-naive metastatic castration-resistant prostate cancer (mCRPC)
    George, D. J.
    Ramaswamy, K.
    Yang, H.
    Liu, Q.
    Zhang, A.
    Greatsinger, A.
    Ivanova, J.
    Thompson, B.
    Emir, B.
    Hong, A.
    Freedland, S. J.
    ANNALS OF ONCOLOGY, 2023, 34 : S989 - S990
  • [23] A real-world registry of patients with metastatic castration-resistant prostate cancer (mCRPC): REMPRO study.
    Gonzalez, Francisco
    Kodagali, Rohit
    Tung, Teresa
    Masoud, Mohamed
    Rajadhyaksha, Viraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] Real-world biomarker testing patterns in metastatic castration-resistant prostate cancer patients
    Blanc, Simon
    Adeboyeje, Gboyega
    Lee, Liam
    Gart, Mike
    Saunders, William
    Wang, Brandon
    Dave, Poras
    English, Sandy
    Varughese, Prateesh
    Sillah, Arthur
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study
    Liontos, M.
    Bournakis, E.
    Bournakis, A.
    Kostouros, E.
    Zolota, V.
    Papatheodoridi, A. P.
    Karalis, K.
    Kyriazoglou, A.
    Zakopoulou, R.
    Vasili, E.
    Tzovaras, A.
    Dimitriadis, I.
    Emmanouil, G.
    Mauri, D.
    Christodoulou, C.
    Tsiatas, M.
    Zagouri, F.
    Bamias, A.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [26] Real-world treatment with abiraterone acetate in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC)
    Boegemann, Martin
    Hatzinger, Martin
    Hercher, Dirko
    Matus, Geoffrey
    Everaert, Els Grieta
    Dopchie, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [27] Real-world treatment patterns among men with metastatic castration-resistant prostate cancer (mCRPC) in the US Medicare population.
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 406 - 406
  • [28] Epidemiology and mortality of metastatic castration-resistant prostate cancer (mCRPC) in a managed care population in the United States.
    Wallace, Katrine
    Landsteiner, Adrienne
    Bunner, Scott
    Engel-Nitz, Nicole
    Luckenbaugh, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Liver metastases (LM) to predict for short overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
    Kelly, William Kevin
    Halabi, Susan
    Carducci, Michael Anthony
    George, Daniel J.
    Mahoney, John Francis
    Stadler, Walter Michael
    Morris, Michael J.
    Kantoff, Philip W.
    Monk, J. P.
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine C.
    Yong, Christina M.
    Burningham, Zachary
    Gupta, Sumati
    Narayanan, Sujata
    Lin, Shih-Wen
    Carroll, Susheela
    Mhatre, Shivani K.
    Graff, Julie N.
    Dreicer, Robert
    Sauer, Brian C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 1.e1 - 1.e10